Trials / Completed
CompletedNCT00234936
Quality of Life Study With Adalimumab in Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the ability of adalimumab combined with methotrexate to improve the quality of life in patients with active RA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adalimumab | |
| DRUG | Methotrexate |
Timeline
- Start date
- 2003-12-01
- First posted
- 2005-10-10
- Last updated
- 2007-10-03
Source: ClinicalTrials.gov record NCT00234936. Inclusion in this directory is not an endorsement.